...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Genetic characterization of fluoroquinolone-resistant Streptococcus pneumoniae strains isolated during ciprofloxacin therapy from a patient with bronchiectasis.
【24h】

Genetic characterization of fluoroquinolone-resistant Streptococcus pneumoniae strains isolated during ciprofloxacin therapy from a patient with bronchiectasis.

机译:环丙沙星治疗期间从支气管扩张患者中分离出的对氟喹诺酮类耐药的肺炎链球菌菌株的遗传特征。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Five Spain(9V-3) Streptococcus pneumoniae strains were isolated from a patient with bronchiectasis who had received long-term ciprofloxacin therapy. One ciprofloxacin-susceptible strain was isolated before treatment, and four ciprofloxacin-resistant strains were isolated during treatment. The resistant strains were derived from the susceptible strain either by a parC mutation (low-level resistance) or by parC and gyrA mutations (high-level resistance). This study shows that ciprofloxacin therapy in a patient colonized by susceptible S. pneumoniae may select fluoroquinolone-resistant mutants.
机译:从长期接受环丙沙星治疗的支气管扩张患者中分离出五株西班牙(9V-3)肺炎链球菌菌株。在治疗前分离出一株对环丙沙星敏感的菌株,在治疗过程中分离出四株对环丙沙星耐药的菌株。抗性菌株是通过parC突变(低水平抗性)或parC和gyrA突变(高水平抗性)从易感菌株衍生而来的。这项研究表明,在易感肺炎链球菌定植的患者中,环丙沙星治疗可能会选择对氟喹诺酮类耐药的突变体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号